ECR to give Cephalon rights to Amrix
FRAZER, Pa. ECR Pharmaceuticals has agreed to give the rights to their drug AMRIX to Cephalon. AMRIX is used for relief of muscle spasms associated with acute, painful musculoskeletal conditions.
The Food and Drug Administration approved the drug in February 2007 in 15 and 30 mgs. The drug is a one-a-day, extended release version of Flexeril. The medication will be a more convenient dosage of Flexeril and its generic Cyclobenzaprine HCl, which is taken three times daily.
The product will be made available in the United States later this year. The drug was acquired under a $100 million cash agreement, which could increase depending on sales milestones.
According to the IMS, cyclobenzaprine HCl represents 37 percent of the 45 million prescriptions written for muscle relaxants in 2006.
United Supermarkets to open first health care clinics in west Texas
LUBBOCK, Texas United Supermarkets, a regional family-owned grocery chain with stores in 26 markets throughout north and west Texas is joining forces with Family Medicine Centers to offer a Living Well ExpressCare clinic in its Amarillo, Texas store beginning next month.
The clinic will offer primary medical services to store guests at United’s 45th and Bell location beginning Sept. 1. It will be located next to the pharmacy, allowing patients to get their prescriptions filled immediately at the same location.
United announced that similar facilities, the first in-store health clinics in west Texas, also are under construction in two United stores in Lubbock, as well as the new Market Street store being built in Frisco, near Dallas, according to the retailer.
“The need for accessible, affordable, high-quality health care in our country has never been greater, as studies indicate that nearly a third of the U.S. population does not have a family physician,” stated Mark Yowell, Specialty Division vice president of United Supermarkets. “[The clinics] “will allow us to focus attention on the wellness and nutrition products and services available in our stores.”
The facility will be open seven days a week, maintaining operating hours similar to those of the store’s pharmacy. It will be staffed by a licensed nurse practitioner or physician assistant under the supervision of a licensed physician.
FDA approves Acatvis’ generic Duragesic patch
MORRISTOWN, N.J. Actavis, the generic pharmaceutical company announced today that it has received approval from the Food and Drug Administration to market Fentanyl, the generic equivalent of the pain patch Duragesic.
President and chief executive officer Robert Wessmann said, “The addition of transdermal fentanyl is representative of our continued effort to expand the depth and breadth of our product portfolio, and highlights our product development expertise in specialty generic products.”
Annually, the brand and generic sales of Fentanyl in the U.S. were approximately $1.2 billion for the twelve months ending June 2007 according to IMS health data.